152 related articles for article (PubMed ID: 34152313)
21. Recent Developments in SARS-CoV-2 Neutralizing Antibody Detection Methods.
Banga Ndzouboukou JL; Zhang YD; Fan XL
Curr Med Sci; 2021 Dec; 41(6):1052-1064. PubMed ID: 34935114
[TBL] [Abstract][Full Text] [Related]
22. Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants.
Ikegame S; Siddiquey MNA; Hung CT; Haas G; Brambilla L; Oguntuyo KY; Kowdle S; Chiu HP; Stevens CS; Vilardo AE; Edelstein A; Perandones C; Kamil JP; Lee B
Nat Commun; 2021 Jul; 12(1):4598. PubMed ID: 34312390
[TBL] [Abstract][Full Text] [Related]
23. A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples.
Sancilio AE; D'Aquila RT; McNally EM; Velez MP; Ison MG; Demonbreun AR; McDade TW
Sci Rep; 2021 Jul; 11(1):15321. PubMed ID: 34321523
[TBL] [Abstract][Full Text] [Related]
24. Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector.
Liang Z; Wu X; Wu J; Liu S; Tong J; Li T; Yu Y; Zhang L; Zhao C; Lu Q; Qin H; Nie J; Huang W; Wang Y
Emerg Microbes Infect; 2023 Dec; 12(2):e2261566. PubMed ID: 37727107
[No Abstract] [Full Text] [Related]
25. Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine.
Bradley T; Grundberg E; Selvarangan R; LeMaster C; Fraley E; Banerjee D; Belden B; Louiselle D; Nolte N; Biswell R; Pastinen T; Myers A; Schuster J
N Engl J Med; 2021 May; 384(20):1959-1961. PubMed ID: 33755375
[No Abstract] [Full Text] [Related]
26. Shedding of infectious SARS-CoV-2 by hospitalized COVID-19 patients in relation to serum antibody responses.
Glans H; Gredmark-Russ S; Olausson M; Falck-Jones S; Varnaite R; Christ W; Maleki KT; Karlberg ML; Broddesson S; Falck-Jones R; Bell M; Johansson N; Färnert A; Smed-Sörensen A; Klingström J; Bråve A
BMC Infect Dis; 2021 May; 21(1):494. PubMed ID: 34044758
[TBL] [Abstract][Full Text] [Related]
27. Flow cytometry multiplexed method for the detection of neutralizing human antibodies to the native SARS-CoV-2 spike protein.
Horndler L; Delgado P; Abia D; Balabanov I; Martínez-Fleta P; Cornish G; Llamas MA; Serrano-Villar S; Sánchez-Madrid F; Fresno M; van Santen HM; Alarcón B
EMBO Mol Med; 2021 Mar; 13(3):e13549. PubMed ID: 33471406
[TBL] [Abstract][Full Text] [Related]
28. Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
Patel EU; Bloch EM; Clarke W; Hsieh YH; Boon D; Eby Y; Fernandez RE; Baker OR; Keruly M; Kirby CS; Klock E; Littlefield K; Miller J; Schmidt HA; Sullivan P; Piwowar-Manning E; Shrestha R; Redd AD; Rothman RE; Sullivan D; Shoham S; Casadevall A; Quinn TC; Pekosz A; Tobian AAR; Laeyendecker O
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33139419
[TBL] [Abstract][Full Text] [Related]
29. Effective screening of SARS-CoV-2 neutralizing antibodies in patient serum using lentivirus particles pseudotyped with SARS-CoV-2 spike glycoprotein.
Tandon R; Mitra D; Sharma P; McCandless MG; Stray SJ; Bates JT; Marshall GD
Sci Rep; 2020 Nov; 10(1):19076. PubMed ID: 33154514
[TBL] [Abstract][Full Text] [Related]
30. A Structural Landscape of Neutralizing Antibodies Against SARS-CoV-2 Receptor Binding Domain.
Niu L; Wittrock KN; Clabaugh GC; Srivastava V; Cho MW
Front Immunol; 2021; 12():647934. PubMed ID: 33995366
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
Nielsen SS; Vibholm LK; Monrad I; Olesen R; Frattari GS; Pahus MH; Højen JF; Gunst JD; Erikstrup C; Holleufer A; Hartmann R; Østergaard L; Søgaard OS; Schleimann MH; Tolstrup M
EBioMedicine; 2021 Jun; 68():103410. PubMed ID: 34098342
[TBL] [Abstract][Full Text] [Related]
32. Aptamer BC 007's Affinity to Specific and Less-Specific Anti-SARS-CoV-2 Neutralizing Antibodies.
Haberland A; Krylova O; Nikolenko H; Göttel P; Dallmann A; Müller J; Weisshoff H
Viruses; 2021 May; 13(5):. PubMed ID: 34069827
[TBL] [Abstract][Full Text] [Related]
33. A 10-Minute "Mix and Read" Antibody Assay for SARS-CoV-2.
Rusanen J; Kareinen L; Levanov L; Mero S; Pakkanen SH; Kantele A; Amanat F; Krammer F; Hedman K; Vapalahti O; Hepojoki J
Viruses; 2021 Jan; 13(2):. PubMed ID: 33498157
[TBL] [Abstract][Full Text] [Related]
34. Evaluation and correlation between SARS-CoV-2 neutralizing and binding antibodies in convalescent and vaccinated subjects.
Manenti A; Gianchecchi E; Dapporto F; Leonardi M; Cantaloni P; Fattorini F; Piu P; Bollati V; Pastorino U; Apolone G; Sozzi G; Montomoli E
J Immunol Methods; 2022 Jan; 500():113197. PubMed ID: 34843712
[TBL] [Abstract][Full Text] [Related]
35. Saliva-Based ELISAs for Effective SARS-CoV-2 Antibody Monitoring in Vaccinated Individuals.
Casian JG; Angel AN; Lopez R; Bagos C; MacMullan MA; Bui ML; Chellamathu P; Das S; Turner F; Slepnev V; Ibrayeva A
Front Immunol; 2021; 12():701411. PubMed ID: 34539632
[TBL] [Abstract][Full Text] [Related]
36. Evaluating SARS-CoV-2 spike and nucleocapsid proteins as targets for antibody detection in severe and mild COVID-19 cases using a Luminex bead-based assay.
Mariën J; Ceulemans A; Michiels J; Heyndrickx L; Kerkhof K; Foque N; Widdowson MA; Mortgat L; Duysburgh E; Desombere I; Jansens H; Van Esbroeck M; Ariën KK
J Virol Methods; 2021 Feb; 288():114025. PubMed ID: 33227340
[TBL] [Abstract][Full Text] [Related]
37. CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.
Lien CE; Lin YJ; Chen C; Lian WC; Kuo TY; Campbell JD; Traquina P; Lin MY; Liu LT; Chuang YS; Ko HY; Liao CC; Chen YH; Jan JT; Ma HH; Sun CP; Lin YS; Wu PY; Wang YC; Tao MH; Lin YL
Sci Rep; 2021 Apr; 11(1):8761. PubMed ID: 33888840
[TBL] [Abstract][Full Text] [Related]
38. Human Milk from Previously COVID-19-Infected Mothers: The Effect of Pasteurization on Specific Antibodies and Neutralization Capacity.
van Keulen BJ; Romijn M; Bondt A; Dingess KA; Kontopodi E; van der Straten K; den Boer MA; Burger JA; Poniman M; Bosch BJ; Brouwer PJM; de Groot CJM; Hoek M; Li W; Pajkrt D; Sanders RW; Schoonderwoerd A; Tamara S; Timmermans RAH; Vidarsson G; Stittelaar KJ; Rispens TT; Hettinga KA; van Gils MJ; Heck AJR; van Goudoever JB
Nutrients; 2021 May; 13(5):. PubMed ID: 34068142
[TBL] [Abstract][Full Text] [Related]
39. Early detection of neutralizing antibodies against SARS-CoV-2 in COVID-19 patients in Thailand.
Putcharoen O; Wacharapluesadee S; Chia WN; Paitoonpong L; Tan CW; Suwanpimolkul G; Jantarabenjakul W; Ruchisrisarod C; Wanthong P; Sophonphan J; Chariyavilaskul P; Wang LF; Hemachudha T
PLoS One; 2021; 16(2):e0246864. PubMed ID: 33577615
[TBL] [Abstract][Full Text] [Related]
40. SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
Wibmer CK; Ayres F; Hermanus T; Madzivhandila M; Kgagudi P; Oosthuysen B; Lambson BE; de Oliveira T; Vermeulen M; van der Berg K; Rossouw T; Boswell M; Ueckermann V; Meiring S; von Gottberg A; Cohen C; Morris L; Bhiman JN; Moore PL
Nat Med; 2021 Apr; 27(4):622-625. PubMed ID: 33654292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
